Intelligent organizations prioritize investments in machine learning and real-time data to improve decision making, accelerate revenue generation efforts, reduce operational expenses and protect ...
In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results